These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27545495)

  • 1. Paclitaxel-induced cystoid macular oedema.
    Chang SY; Tsai SH; Chen LJ; Chan WC
    Acta Ophthalmol; 2018 Aug; 96(5):e649-e650. PubMed ID: 27545495
    [No Abstract]   [Full Text] [Related]  

  • 2. Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.
    Nomi N; Ota M; Fukumura M; Nuno Y; Hatano M; Wakuta M; Yanai R; Kimura K
    Jpn J Ophthalmol; 2018 Mar; 62(2):163-167. PubMed ID: 29270811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Macula Structural and Functional Assessment in Nab-Paclitaxel-Related Cystoid Macular Edema.
    Kwok L; Mahmood A; Kumar S; Chang A
    Ophthalmic Surg Lasers Imaging Retina; 2024 Jul; 55(7):408-411. PubMed ID: 38531022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral cystoid macular edema in a patient with taxane-based chemotherapy.
    Padrón Pérez N; Rubio Caso MJ; Arias Barquet L; Caminal Mitjana JM
    Can J Ophthalmol; 2013 Feb; 48(1):e3-4. PubMed ID: 23419309
    [No Abstract]   [Full Text] [Related]  

  • 5. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography Imaging of Taxane-Associated Cystoid Macular Edema.
    Sridhar J; Shahlaee A; Ehmann D; Samara WA; Rahimy E; Ho AC; Chiang A
    Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):176-9. PubMed ID: 26878452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographically silent cystoid macular oedema secondary to paclitaxel therapy.
    Georgakopoulos CD; Makri OE; Vasilakis P; Exarchou A
    Clin Exp Optom; 2012 Mar; 95(2):233-6. PubMed ID: 22023333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.
    Rahimy E; Sarraf D
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):187-9. PubMed ID: 23421925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of cystoid macular edema associated with Paclitaxel chemotherapy.
    Ham DS; Lee JE; Kim HW; Yun IH
    Korean J Ophthalmol; 2012 Oct; 26(5):388-90. PubMed ID: 23060727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.
    Park E; Goldberg NR; Adams S
    Anticancer Drugs; 2016 Jul; 27(6):580-4. PubMed ID: 26982237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment.
    Tezcan Y; Surmeli M; Tastekin D; Koc M
    Arch Iran Med; 2015 Sep; 18(9):606-7. PubMed ID: 26317603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction.
    Freitas-da-Costa P; Brandão E; Bragança T; Falcão-Reis F; Carneiro A
    Cutan Ocul Toxicol; 2015; 34(4):347-9. PubMed ID: 25597372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-leaking Cystoid Maculopathy Secondary to Systemic Paclitaxel.
    Modi D; Dubovy SR
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):183-6. PubMed ID: 23429715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
    Rahman HT; Yeh S; Bergstrom CS
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of Müller Cell Dysfunction as the Pathogenesis of Paclitaxel Maculopathy.
    Nakao S; Ikeda Y; Emi Y; Ishibashi T
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):81-4. PubMed ID: 26731216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography findings in niacin maculopathy.
    Dajani HM; Lauer AK
    Can J Ophthalmol; 2006 Apr; 41(2):197-200. PubMed ID: 16767207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional optical coherence tomography study in patients on taxane-based therapy and a case report with the literature review.
    Kaya M; Atas F; Gulsum Guc Z; Oztop I; Durak I; Saatci AO
    Cutan Ocul Toxicol; 2020 Sep; 39(3):287-293. PubMed ID: 32619362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel maculopathy.
    Joshi MM; Garretson BR
    Arch Ophthalmol; 2007 May; 125(5):709-10. PubMed ID: 17502517
    [No Abstract]   [Full Text] [Related]  

  • 19. The mystery of angiographically silent macular oedema due to taxanes.
    Kuznetcova TI; Cech P; Herbort CP
    Int Ophthalmol; 2012 Jun; 32(3):299-304. PubMed ID: 22484725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nepafenac for cystoid macular oedema secondary to paclitaxel.
    Tapia Quijada HE; Quijada Fumero E; Mesa Lugo FI; Serrano García M; Betancor Caro N
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Aug; 96(8):434-437. PubMed ID: 34340782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.